Press release
Small Cell Lung Cancer Pipeline Outlook, Therapies, Companies 2024
Small Cell Lung Cancer Pipeline
Discover the latest drugs and treatment options in the Small Cell Lung Cancer Pipeline. Dive into DelveInsight's comprehensive report today! @ Small Cell Lung Cancer Pipeline Outlook- https://www.delveinsight.com/sample-request/small-cell-lung-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Small Cell Lung Cancer Pipeline Report
• In September 2024:- Amgen- A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects with Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy.
• In September 2024:- Biotheus Inc.- PM8002 is a bispecific antibody targeting PD-L1 and VEGF. This study to evaluate the efficacy and safety of PM8002 in combination with etoposide and platinum in first-line treatment of extensive-stage small cell lung cancer
• July 2024:- Merck Sharp & Dohme LLC- A Phase 3, Multicenter, Randomized, Double-Blind Study of MK-7684 With Pembrolizumab as a Coformulation (MK-7684A) Versus Pembrolizumab Monotherapy as First Line Treatment for Participants With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer. The goal of this study is to learn if people who receive vibostolimab and pembrolizumab live longer overall and without the cancer getting worse than people who receive pembrolizumab alone.
• July 2024:- AbbVie- A Randomized, Phase 2/3 Study to Evaluate the Optimal Dose, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic and may require frequent medical assessments, blood tests, questionnaires, and scans.
• DelveInsight's Small Cell Lung Cancer pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for Small Cell Lung Cancer treatment.
• The leading Small Cell Lung Cancer Companies include Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A., Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics, Inc., Arch Biopartners, Ibudilast, and others.
• Promising Small Cell Lung Cancer Therapies in the various stages of development include Amivantamab, Lazertinib, Pemetrexed 500 mg, AL8326 tablets, durvalumab, and others.
Stay ahead with the most recent pipeline outlook for Small Cell Lung Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Small Cell Lung Cancer Approved Drugs- https://www.delveinsight.com/sample-request/small-cell-lung-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Small Cell Lung Cancer Emerging Drugs Profile
• AMG 757: Amgen
AMG 757 is a half-life extended (HLE) anti- delta-like ligand 3 (DLL3) x anti-CD3 BiTE (bispecific T cell engager) molecule. It is being investigated in Phase I clinical studies for the treatment of prostate cancer and Small cell lung cancer.
• APG-1252: Ascentage Pharma
APG-1252 is a highly potent, small-molecule based Bcl-2 family protein inhibitor drug. APG-1252 is designed to treat SCLC, NSCLC, lymphoma, and other solid tumors by selectively blocking Bcl-2 and Bcl-xL to restore the apoptosis process. The drug is in Phase I/II clinical studies for the treatment of SCLC.
Explore groundbreaking therapies and clinical trials in the Small Cell Lung Cancer Pipeline. Access DelveInsight's detailed report now! @ Small Cell Lung Cancer Treatment Drugs- https://www.delveinsight.com/sample-request/small-cell-lung-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Small Cell Lung Cancer Companies
Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A., Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics, Inc., Arch Biopartners, Ibudilast, and others.
Small Cell Lung Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
• Molecule Type
Small Cell Lung Cancer Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Unveil the future of Small Cell Lung Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Small Cell Lung Cancer Market Drivers and Barriers- https://www.delveinsight.com/sample-request/small-cell-lung-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Small Cell Lung Cancer Pipeline Report
• Coverage- Global
• Small Cell Lung Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Small Cell Lung Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Small Cell Lung Cancer Companies- Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A., Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics, Inc., Arch Biopartners, Ibudilast, and others.
• Small Cell Lung Cancer Therapies- Amivantamab, Lazertinib, Pemetrexed 500 mg, AL8326 tablets, durvalumab, and others.
Get the latest on Small Cell Lung Cancer Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Small Cell Lung Cancer Companies, Key Products and Unmet Needs- https://www.delveinsight.com/sample-request/small-cell-lung-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Small Cell Lung Cancer: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Small Cell Lung Cancer - DelveInsight's Analytical Perspective
7. In-depth Commercial Assessment
8. Small Cell Lung Cancer Collaboration Deals
9. Late Stage Products (Phase III)
10. Pembrolizumab: Merck & Co
11. Drug profiles in the detailed report…..
12. Mid Stage Products (Phase II)
13. Dostarlimab: GlaxoSmithKline
14. Drug profiles in the detailed report…..
15. Early Stage Products (Phase I)
16. AMG 757: Amgen
17. Drug profiles in the detailed report…..
18. Preclinical/Discovery Stage Products
19. S 055746: Vernalis
20. Drug profiles in the detailed report…..
21. Inactive Products
22. Small Cell Lung Cancer Key Companies
23. Small Cell Lung Cancer Key Products
24. Small Cell Lung Cancer- Unmet Needs
25. Small Cell Lung Cancer- Market Drivers and Barriers
26. Small Cell Lung Cancer- Future Perspectives and Conclusion
27. Small Cell Lung Cancer Analyst Views
28. Small Cell Lung Cancer Key Companies
29. Appendix
List of Top Selling Market Research Reports in 2024
Abdominal Aortic Aneurysm Market- https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-market
Acute Myeloid Leukemia Market- https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-market
Adult T-cell Leukemia Market- https://www.delveinsight.com/report-store/adult-t-cell-leukemia-lymphoma-market
Alcoholic Hepatitis Market- https://www.delveinsight.com/report-store/alcoholic-hepatitis-market
Beta Thalassemia Market- https://www.delveinsight.com/report-store/beta-thalassemia-market
Blastomycosis Market- https://www.delveinsight.com/report-store/blastomycosis-market
Carbapenem-resistant Enterobacteriaceae Infection Market- https://www.delveinsight.com/report-store/carbapenem-resistant-enterobacteriaceae-infection-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Central Retinal Vein Occlusion Market- https://www.delveinsight.com/report-store/central-retinal-vein-occlusion-market
Clostridium Difficile Infections Market- https://www.delveinsight.com/report-store/clostridium-difficile-infections-clostridium-difficile-associated-disease-market
Congenital Heart Defect Market- https://www.delveinsight.com/report-store/congenital-heart-defect-devices-market
Diabetic Gastroparesis Market- https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size
Familial Adenomatous Polyposis Market- https://www.delveinsight.com/report-store/familial-adenomatous-polyposis-market
Gastroparesis Market- https://www.delveinsight.com/report-store/gastroparesis-market
Genital Herpes Market- https://www.delveinsight.com/report-store/genital-herpes-market
Trauma Fixation Devices Market- https://www.delveinsight.com/report-store/trauma-devices-market
Vascular Imaging Devices Market- https://www.delveinsight.com/report-store/vascular-imaging-market-market
Venous Thromboembolism Market- https://www.delveinsight.com/report-store/venous-thromboembolism-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Yash Bhardwaj
info@delveinsight.com
+91-9650213330
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Small Cell Lung Cancer Pipeline Outlook, Therapies, Companies 2024 here
News-ID: 3667619 • Views: …
More Releases from DelveInsight Business Research LLP
Skin Neoplasm Market Size is Set for Rapid Growth as Innovative Treatments and R …
The Skin Neoplasm market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Merck Sharp & Dohme LLC, Eli Lilly and Company, Novartis Pharmaceuticals, Hoffmann-La Roche, Sanofi, GlaxoSmithKline, Boehringer Ingelheim
[Nevada, United Delveinsight] - DelveInsight's "Skin Neoplasm Market Insights, Epidemiology, and Market Forecast 2032." report offers a detailed examination of Skin Neoplasm, covering historical and…
Medical Marijuana Market Size is Set for Rapid Growth as Innovative Treatments a …
The Medical Marijuana market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Fenix Innovation Group, Neurotech International, Cymra Life Sciences., GW Pharmaceuticals, Aphria Inc, Columbia Care Inc., UConn Health
[Nevada, United States] - DelveInsight's "Medical Marijuana Market Insights, Epidemiology, and Market Forecast 2032." report offers a detailed examination of Medical Marijuana, covering historical and…
Soft Tissue Sarcoma Treatment Drugs, Clinical Trials, Pipeline Insights, and Com …
DelveInsight's, "Soft Tissue Sarcoma Pipeline Insight 2024" report provides comprehensive insights about 125+ companies and 130+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Soft Tissue Sarcoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Soft…
Idiopathic Pulmonary Fibrosis Treatment Drugs, Clinical Trials, Pipeline Insight …
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Idiopathic Pulmonary Fibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest…
More Releases for Small
Global Small Gas Engines Market, Global Small Gas Engines Industry, Covid-19 Imp …
The Small Gas Engines market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Small Gas Engines Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Small Gas Engines market. The report focuses on well-known providers…
Small Business Success Platform
OwnersPath.com has developed a small business success platform that helps businesses to locate and pre-qualify for financing, build strong business credit scores, optimize their online marketing, maximize the owners earnings, and increase the business value.
The system allows business owners to first run a success scan on their business that returns 150 data points on their business and establishes a base line for the owners as to where their business is…
Small Appliances Market: Strategic Assessment of Emerging Technologies in Small …
Small appliances market is forecasted to grow substantially in all market segments through 2016 owing to the rise in living standards and need for more comfort. Small appliance industry consists of home appliances that are movable or partially movable and can be used on tables, counters, or other platforms. The growth of small appliances market is expected to be driven by product innovation, upgradation of existing products, and value-added features…
Theater Slim PCR Cycler - Small Footprint, Small Price, Great Flexibility
MoBiTec is selling an incredibly small, light, and slim (4 cm), yet fully functional PCR instrument - The Theater Slim PCR Cycler. It is beneficial to small-sized labs and in-the-field research.
The Theater Slim PCR Cycler, manufactured by Coyote Bioscience, is a new generation of PCR mini cycler, extremly small and thin. The thickness is merely 4 cm. It has a user-friendly interface employing leading touch-screen technology. Any person can…
Big Data – Small Devices
Are we facing a new way of doing data science? Do we need novel methods for machine learning? On Monday, March 7, leading IT experts will convene at the German Center for Research and Innovation (GCRI) in New York for a discussion on Big Data and resource-restricted systems.
NEW YORK (March 3, 2016) – The amount of digitally recorded information in today’s world is growing exponentially. Massive volumes of user-generated information…
Small Weddings Become Fashionable
A recent survey of brides done by a commercial bridal establishment determined that: 54% of brides reduced their wedding budgets due to the economy. 45% of the brides said that they only planned to spend $10,000 on their weddings. Also notable was the fact that 89% of brides considered having a small wedding to save money.
This came to the attention of wedding planner Yusuf Jaafar, and in response to…
